Clinical Trial Update: IONSYS Feasibility Study [Phase 4]

View source ↗

Summary

Feasibility study for IONSYS in spinal injury was withdrawn in Phase 4.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinal Cord Injury

Drugs mentioned

• IONSYS

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Spinal Injury | Phase 4 | Status: WITHDRAWN